Literature DB >> 19259881

Effect of lipophilicity of Mn (III) ortho N-alkylpyridyl- and diortho N, N'-diethylimidazolylporphyrins in two in-vitro models of oxygen and glucose deprivation-induced neuronal death.

Lisa Wise-Faberowski1, David S Warner, Ivan Spasojevic, Ines Batinic-Haberle.   

Abstract

In vivo investigations have confirmed the beneficial effects of hydrophilic, cationic Mn(III) porphyrin-based catalytic antioxidants in different models of oxidative stress. Using a cell culture model of rat mixed neuronal/glial cells, this study investigated the effect of MnTnOct-2-PyP5+ on oxygen and glucose deprivation (OGD)-induced cell death as compared to the effects of widely studied hydrophilic analogues MnTE-2-PyP5+ and MnTDE-2-ImP5+ and a standard compound, dizocilpine (MK-801). It was hypothesized that the octylpyridylporphyrin, MnTnOct-2-PyP5+, a lipophilic but equally potent antioxidant as the other two porphyrins, would be more efficacious in reducing OGD-induced cell death due to its higher bioavailability. Cell death was evaluated at 24 h using lactate dehydrogenase (LDH) release and propidium iodide staining. At concentrations from 3-100 microM, all three porphyrins reduced cell death as compared to cultures exposed to OGD alone, the effects depending upon the concentrations and type of treatment. To assess the effect of lipophilicity the additional experiments were performed using submicromolar concentrations of MnTnOct-2-PyP5+ in an organotypic hippocampal slice model of OGD with propidium iodide and Sytox staining. When compared to oxygen and glucose deprivation alone, concentrations of MnTnOct-2-PyP5+ as low as 0.01 microM significantly (p<0.001; power 1.0) reduced neuronal cells similar to control. This is the first in vitro study on the mammalian cells which indicates that MnTnOct-2-PyP5+ is up to 3000-fold more efficacious than equally potent hydrophilic analogues, due entirely to its increased bioavailability. Such remarkable increase in efficacy parallels 5.7-orders of magnitude increase in lipophilicity of MnTnOct-2-PyP5+ (log P=-0.77) when compared to MnTE-2-PyP5+ (log POW=-6.43), POW being partition coefficient between n-octanol and water.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259881      PMCID: PMC3160267          DOI: 10.1080/10715760902736283

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  28 in total

1.  Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity.

Authors:  Ayako Okado-Matsumoto; Ines Batinić-Haberle; Irwin Fridovich
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

2.  Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane.

Authors:  L Wise-Faberowski; M K Raizada; C Sumners
Journal:  Anesth Analg       Date:  2001-11       Impact factor: 5.108

3.  A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.

Authors:  Benjamin J Moeller; Ines Batinic-Haberle; Ivan Spasojevic; Zahid N Rabbani; Mitchell S Anscher; Zeljko Vujaskovic; Mark W Dewhirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

4.  Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.

Authors:  G B Mackensen; M Patel; H Sheng; C L Calvi; I Batinic-Haberle; B J Day; L P Liang; I Fridovich; J D Crapo; R D Pearlstein; D S Warner
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model.

Authors:  Stephen B Leinenweber; Huaxin Sheng; John R Lynch; Haichen Wang; Ines Batinić-Haberle; Daniel T Laskowitz; James D Crapo; Robert D Pearlstein; David S Warner
Journal:  Eur J Pharmacol       Date:  2006-02-15       Impact factor: 4.432

6.  Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.

Authors:  Ivan Spasojević; Yumin Chen; Teresa J Noel; Yiqun Yu; Marsha P Cole; Lichun Zhang; Yunfeng Zhao; Daret K St Clair; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2007-01-13       Impact factor: 7.376

7.  EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.

Authors:  Vanessa P M van Empel; Anne T Bertrand; Ralph J van Oort; Roel van der Nagel; Markus Engelen; Harold V van Rijen; Pieter A Doevendans; Harry J Crijns; Susan L Ackerman; Wim Sluiter; Leon J De Windt
Journal:  J Am Coll Cardiol       Date:  2006-07-25       Impact factor: 24.094

8.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

9.  Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity.

Authors:  Lisa Wise-Faberowski; Mitsuo Aono; Robert D Pearlstein; David S Warner
Journal:  Anesth Analg       Date:  2004-12       Impact factor: 5.108

10.  Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia.

Authors:  Huaxin Sheng; Jan J Enghild; Russell Bowler; Manisha Patel; Ines Batinić-Haberle; Carla L Calvi; Brian J Day; Robert D Pearlstein; James D Crapo; David S Warner
Journal:  Free Radic Biol Med       Date:  2002-10-01       Impact factor: 7.376

View more
  8 in total

Review 1.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Artak Tovmasyan; Julio S Reboucas; Xiaodong Ye; Kam W Leong; Mark W Dewhirst; Zeljko Vujaskovic; Ludmil Benov; Ivan Spasojevic
Journal:  Free Radic Biol Med       Date:  2011-05-06       Impact factor: 7.376

Review 3.  Manganese superoxide dismutase, MnSOD and its mimics.

Authors:  Sumitra Miriyala; Ivan Spasojevic; Artak Tovmasyan; Daniela Salvemini; Zeljko Vujaskovic; Daret St Clair; Ines Batinic-Haberle
Journal:  Biochim Biophys Acta       Date:  2011-12-09

4.  Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.

Authors:  Zahid N Rabbani; Ivan Spasojevic; Xiuwu Zhang; Benjamin J Moeller; Sinisa Haberle; Jeannette Vasquez-Vivar; Mark W Dewhirst; Zeljko Vujaskovic; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2009-07-08       Impact factor: 7.376

5.  High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli.

Authors:  Ivan Kos; Ludmil Benov; Ivan Spasojević; Júlio S Rebouças; Ines Batinić-Haberle
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

Review 6.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

7.  Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.

Authors:  Ivan Kos; Júlio S Rebouças; Gilson DeFreitas-Silva; Daniela Salvemini; Zeljko Vujaskovic; Mark W Dewhirst; Ivan Spasojević; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2009-04-08       Impact factor: 7.376

Review 8.  Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.

Authors:  Artak Tovmasyan; Huaxin Sheng; Tin Weitner; Amanda Arulpragasam; Miaomiao Lu; David S Warner; Zeljko Vujaskovic; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Med Princ Pract       Date:  2012-10-16       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.